The results obtained reveal that CerK protein expression is markedly reduced in all experimental models of cancer-induced atrophy, demonstrating that the CerK/C1P axis plays a role of molecular regulator of SkM mass in these conditions. The gene discussed is CERK; the disease is cancer.